{"title":"Oridonin mitigates cerebral ischemic–reperfusion injury via covalent binding to HMGB1 and inhibiting the HMGB1/TLR4/MyD88/NF-κB signaling pathway","authors":"Dandan Liu, Shujie Zhang, Fei Xia, Qiaoli Shi, Hui Zhao, Yinkwan Wong, Yuqing Meng, Yanqing Liu, Yongping Zhu, Xin Tian Chai, Jiale Xing, Huan Tang, Chong Qiu, Peili Wang, Ang Ma, Yì Wáng","doi":"10.1097/hm9.0000000000000181","DOIUrl":"https://doi.org/10.1097/hm9.0000000000000181","url":null,"abstract":"Objective: Ischemic stroke (IS) is a leading cause of mortality and disability worldwide, and effective pharmacological treatments are limited. Oridonin (Ori) has demonstrated neuroprotective potential in IS; however, its underlying mechanisms are still poorly understood. Methods: In vitro, oxygen-glucose deprivation/reperfusion (OGD/R) models were established using mouse neuroblastoma Neuro-2a cells and primary cortical neurons. In vivo, a transient middle cerebral artery occlusion (tMCAO) model was induced in male C57BL/6J mice to simulate cerebral ischemic–reperfusion (I/R) injury. The key targets of Ori were identified using activity-based protein profiling (ABPP). The binding affinity between Ori and its target protein was validated using multiple approaches, including cellular thermal shift assay (CETSA), molecular docking, and biolayer interferometry (BLI). Results: Ori significantly suppressed the expression of inflammatory cytokines in tMCAO- and OGD/R-treated neuronal cells. Target identification revealed that high-mobility group box 1 (HMGB1) protein is the key mediator of the protective effects of Ori against cerebral I/R injury. Mechanistically, Ori covalently binds to cysteine (Cys) 106 of HMGB1, reducing its secretion and proinflammatory activity. Additionally, Ori downregulated cytoplasmic HMGB1 levels and the expression of TLR4 and MyD88, as well as the p-p65/p65 ratio in both OGD/R and tMCAO models. Notably, the HMGB1 inhibitor NecroX-7 conferred protection against OGD/R-induced neuronal injury and tMCAO-induced brain damage in mice, which could not be further modulated by Ori treatment. Conclusions: Our findings demonstrate that Ori confers neuroprotection against brain I/R injury by covalently binding to HMGB1 at Cys106 via its reactive carbon–carbon double bonds, thereby eliminating the proinflammatory activity of HMGB1. This molecular interaction reduces HMGB1 secretion and inhibits the downstream HMGB1/TLR4/MyD88/NF-κB signaling pathway, ultimately attenuating neuroinflammation and ischemic damage.","PeriodicalId":60507,"journal":{"name":"Acupuncture and Herbal Medicine","volume":"6 1","pages":"56-72"},"PeriodicalIF":0.0,"publicationDate":"2026-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147877582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Tamarixetin suppresses neuronal ferroptosis in ischemic stroke rats by targeting and facilitating nuclear factor erythroid-2–related factor 2 expression","authors":"Yanqiu Yang, Mingxia Fang, Qingqi Meng, Yan xia Mi, Libin Xu, Hua Guo, Yueyang Liu, Mingzhou Li, Nanik Siti Aminah, Zipeng Gong, Yue Hou","doi":"10.1097/hm9.0000000000000182","DOIUrl":"https://doi.org/10.1097/hm9.0000000000000182","url":null,"abstract":"Objective: Neuronal ferroptosis has emerged as a promising therapeutic target for ischemic stroke. Tamarixetin, a natural dietary flavonoid, exerts protective effects against ischemic stroke by modulating neuroinflammatory responses and mitigating oxidative stress. However, its potential role in regulating neuronal ferroptosis remains unclear. Methods: A rat model of middle cerebral artery occlusion and reperfusion and an erastin-treated SH-SY5Y cell model were used for in vivo and in vitro experiments, respectively. The neurological function of the rats was evaluated using a series of behavioral tests, the Garcia scoring system, and 2,3,5-triphenyltetrazolium chloride staining. Neuronal damage was detected via immunofluorescence staining and terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate (dUTP) nick-end labeling. Commercial kits, western blotting, and coimmunoprecipitation were used to analyze neuronal ferroptosis and the activation of the Nuclear factor erythroid-2–related factor 2 (Nrf2) signaling pathway. The direct target protein of tamarixetin was examined using the cellular thermal shift assay, drug affinity-responsive target stability assay, surface plasmon resonance, and molecular docking. Cellular Nrf2 was knocked down using small interfering RNA. Results: Tamarixetin mitigated the neurological dysfunctions of middle cerebral artery occlusion and reperfusion (MCAO/R) rats, including motor dysfunction, limb coordination impairment, neurological deficit, cerebral infarction, and reduced neuronal loss. Furthermore, it alleviated neuronal ferroptosis in vivo and in vitro by lowering the levels of iron ions, reactive oxygen species, malondialdehyde, and acyl-CoA synthetase long-chain family member 4 and upregulating the expression of superoxide dismutase, glutathione, glutathione peroxidase 4, heme oxygenase-1, and solute carrier family 7 member 11. Tamarixetin activated the Nrf2 signaling pathway by suppressing Keap1 protein expression, weakening the interaction between Keap1 and Nrf2, upregulating Nrf2 protein expression and nuclear translocation, and promoting antioxidant response element activity. Nrf2 is the direct binding protein of tamarixetin. It specifically interacts with amino acid residues at arginine 72, arginine 515, and lysine 518. The effects of tamarixetin on Nrf2 signaling pathway activation and neuronal ferroptosis inhibition were abrogated in Nrf2 knockdown cells challenged with erastin. Conclusions: Our findings not only identify tamarixetin as a novel ferroptosis inhibitor but also elucidate its mechanism of action via direct binding and Nrf2 pathway activation, providing a promising therapeutic candidate for ischemic stroke.","PeriodicalId":60507,"journal":{"name":"Acupuncture and Herbal Medicine","volume":"6 1","pages":"73-90"},"PeriodicalIF":0.0,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147879777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Daokang Chen, Jiamin Hu, Shaojie Yang, Pan Xie, Manman Ji, Zhengrong Zhang, Michel Baudry, Sheng Zhang, Guoqi Zhu
{"title":"Mechanistic studies of the beneficial effects of Anshen Dingzhi prescription for PTSD treatment: roles of the FKBP5-IKKα-NF-κB-NLRP3 signaling pathway","authors":"Daokang Chen, Jiamin Hu, Shaojie Yang, Pan Xie, Manman Ji, Zhengrong Zhang, Michel Baudry, Sheng Zhang, Guoqi Zhu","doi":"10.1097/hm9.0000000000000164","DOIUrl":"https://doi.org/10.1097/hm9.0000000000000164","url":null,"abstract":"Objective: Anshen Dingzhi prescription (ADP) is an effective remedy for treating post-traumatic stress disorder (PTSD); however, the mechanism underlying its beneficial effects is unclear. This study explores the roles of the neuroinflammation regulated by the FKBP prolyl isomerase 5 (FKBP5)-IκB kinase alpha (IKKα)-nuclear factor kappa-B (NF-κB)-NOD-like receptor thermal protein domain-associated protein 3 (NLRP3) signaling pathway in PTSD. Methods: The primary components of ADP, including ginsenosides Rg1 and Rb1, were quantified using ultra-performance liquid chromatography. Twelve C57BL/6 mice were allocated to control (D0) and experimental groups on days one, seven, and 14 of single prolonged stress (SPS). Eighteen C57BL/6 mice were allocated to control, SPS, and MCC950, an NLRP3 inhibitor (5 mg/kg) groups. Finally, 24 C57BL/6 mice were allocated to control, SPS, paroxetine hydrochloride (PRX), or ADP (18.4 and 36.8 mg/kg) groups. Mice were administered MCC950, PRX, or ADP for 14 days. The open field test and elevated plus maze were used to evaluate anxiety-like behaviors, whereas fear memory extinction was evaluated using the fear memory test. Western blotting was employed to evaluate the expression levels of the FKBP5-IKKα-NF-κB-NLRP3 signaling pathway, tumor necrosis factor-α (TNF-α), interleukin (IL)-6, and IL-1β. The expression of FKBP5 and NLRP3 was further confirmed by immunofluorescence staining. Results: The amounts of ginsenosides Rg1 and Rb1 in ADP were (96.85 ± 1.14) and (9.04 ± 0.22) µg/g, respectively. Compared with the D0 group, the levels of the inflammatory cytokine proteins, TNF-α, IL-6, and IL-1β were elevated 1.33- to 1.51-fold and those of FKBP5-IKKα-NF-κB-NLRP3 signaling pathway were increased 1.16- to 1.41-fold in the hippocampus of the D14 group ( P < 0.05); the fluorescence intensity of FKBP5 and NLRP3 was also markedly increased (1.33–1.79-fold) in the hippocampus of the D14 group ( P < 0.5). Notably, injection of MCC950 (5 mg/kg) reduced the levels of FKBP5-IKKα-NF-κB-NLRP3 (0.80–0.88-fold) and inflammatory cytokines (0.74–0.83-fold), thereby improving the PTSD-like behaviors induced by SPS ( P < 0.05). In addition, ADP (36.8 g/kg) significantly improved PTSD-like behaviors and reduced levels of hippocampal inflammatory cytokines (0.70–0.79-fold) and FKBP5-IKKα-NF-κB-NLRP3 (0.50–0.79-fold) ( P < 0.05) in SPS mice. Conclusion: The results suggest a potential therapeutic benefit of ADP in PTSD due to the inhibition of the FKBP5-IKKα-NF-κB-NLRP3 signaling pathway.","PeriodicalId":60507,"journal":{"name":"Acupuncture and Herbal Medicine","volume":"5 3","pages":"316-327"},"PeriodicalIF":0.0,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147879931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Human pharmacokinetics and drug interaction potential of GuHong: an intravenous herbal formulation for managing ischemic stroke","authors":"Qiuyue Wang, Zhenzhen Ma, Jia-Ye Yuan, Guo-Li Yue, Yun-Fei Feng, Xiaoyan Xia, Weiwei Jia, Feifei Du, Fengqing Wang, Xuan Yu, Chen Cheng, Yühong Huang, Xiaokai Wang, Yi-Mei Zeng, Yanfen Li, Zijing Song, Junling Yang, Chuan Li","doi":"10.1097/hm9.0000000000000155","DOIUrl":"https://doi.org/10.1097/hm9.0000000000000155","url":null,"abstract":"Objective: Unlike for drug-drug interactions, rigorous guidelines for assessing herb-drug interactions are nonexistent. GuHong is an intravenous herbal formulation used as adjunct therapy for the management of ischemic stroke. This investigation aimed to evaluate its potential to precipitate pharmacokinetic drug interactions. To facilitate the potential assessment, a human multi-compound pharmacokinetic study, along with associated supportive studies, was conducted to pinpoint GuHong compounds for testing. Methods: After analyzing the chemical composition of GuHong, a pharmacokinetic study was conducted in healthy subjects who received GuHong intravenously to identify its significantly exposed compounds and their pharmacokinetics. In addition, supportive rat and in vitro studies were conducted to assess the hepatic and renal disposition of these compounds, including their metabolism and transport. The potential of GuHong to precipitate drug interactions was evaluated in vitro using significantly exposed compounds, which were tested for their effects on drug-metabolizing enzymes and drug transporters listed in the ICH M12 Guideline (2024), with a focus on inhibition and induction. Samples were analyzed by liquid chromatography-mass spectrometry. Results: A total of 54 constituents (0.01–27.18 μmol/day) derived from Carthamus tinctorius flowers (Honghua) and N -acetyl-L-glutamine (3,090 μmol/day) were detected in GuHong. Following intravenous administration of GuHong, hydroxysafflor yellow A emerged as the principal circulating compound from Honghua. Saffloquinoside D, kaempferol-3- O -rutinoside, kaempferol-3- O -sophoroside, 8-hydroxycinnamic acid-8- O -glucoside, coumaric acid-4- O -glucoside, and chlorogenic acid, also from Honghua, were detected but at low plasma levels. Hydroxysafflor yellow A, primarily eliminated via glomerular filtration-based renal excretion, exhibited the characteristics of an intravenous “hard drug.” N -Acetyl-L-glutamine was another major circulating compound of GuHong and was eliminated through renal excretion and hydrolysis to L-glutamine. GuHong had a low potential to precipitate pharmacokinetic drug interactions. Conclusions: The low drug interaction potential of GuHong is advantageous for its use in the treatment of ischemic stroke in the context of polypharmacy. The methodology developed here can be applied to the study of other complex herbal medicines for their pharmacokinetic drug interaction potential.","PeriodicalId":60507,"journal":{"name":"Acupuncture and Herbal Medicine","volume":"5 2","pages":"173-192"},"PeriodicalIF":0.0,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147887234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Tetramethylpyrazine attenuates chronic intermittent hypoxia-exacerbated diabetic atherosclerosis: a mechanistic study of the IRE1α-XBP1 signaling pathway","authors":"Binyu Luo, Wenting Wang, Yiwen Li, Jing Cui, Qian Xu, Mengmeng Zhu, Yanfei Liu, Yue Liu","doi":"10.1097/hm9.0000000000000154","DOIUrl":"https://doi.org/10.1097/hm9.0000000000000154","url":null,"abstract":"Objective: A complex relationship exists between obstructive sleep apnea syndrome and diabetes mellitus (DM). Chronic intermittent hypoxia (CIH), which is a core pathological feature of obstructive sleep apnea syndrome, may play an important role in the onset and development of DM-related atherosclerosis (DM-AS). This study aimed to investigate the mechanism of action of tetramethylpyrazine (TMP) in CIH-associated DM-AS. Methods: In vivo , a DM-AS mouse model was established by intraperitoneal injection of streptozotocin combined with a high-fat diet. They were exposed to CIH or normoxic conditions for 8 weeks and received different doses of TMP, rosuvastatin, toyocamycin, and purified water. Glycolipid metabolism, inflammation levels, degree of aortic AS, and expression levels of endoplasmic reticulum stress (ERS) and autophagy proteins were examined in mice. In vitro , human umbilical vein endothelial cells (HUVECs) were treated with high glucose and fat in combination with insulin to establish an insulin-resistant cell model (HUVEC-IR). After pretreatment with 4μ8C (IRE1 inhibitor) and different doses of TMP, intermittent hypoxic intervention was performed. Changes in cell morphology, proliferative activity, glucose consumption, and ability to migrate were observed, and the expression levels of ERS and autophagy proteins were detected. Results: In vivo experiments showed that CIH significantly increased blood glucose levels and Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) ( P < 0.001 or P < 0.05), low-density lipoprotein cholesterol (LDL-C) content ( P < 0.001), and the levels of three inflammatory factors [interleukin-1 beta (IL-1β), IL-6, and tumor necrosis factor-alpha (TNF-α)] in the mice ( P < 0.001) compared with those of the mice with DM alone; moreover, the aortic atherosclerotic (AS) plaque area in CIH mice was significantly enlarged ( P < 0.001). Western blotting results showed that the expressions of aortic IRE1α, XBP1s, Beclin1, and LC3A proteins were significantly increased in CIH mice compared with DM mice ( P < 0.05). After treatment with different doses of TMP, rosuvastatin calcium, and toyocamycin, serum inflammation and lipid levels and plaque area were significantly reduced in mice ( P < 0.001 and P < 0.001, respectively). The expression levels of aortic XBP1s, Beclin1, and LC3A were reduced in TMP- and toyocamycin-treated mice ( P < 0.05). In the in vitro experiments, compared with normoxic cells, the cells treated with intermittent hypoxia (IH) showed a significant decrease in cell migration distance ( P < 0.05), a significant increase in apoptosis rate ( P < 0.001), a substantial increase in proliferation inhibition rate ( P < 0.001), a significant increase in the levels of XBP1s and LC3A proteins ( P < 0.05), and an increase in the number of autophagic vesicles/lysosomes, as observed under transmission electron microscopy. After treatment with different doses of TMP ","PeriodicalId":60507,"journal":{"name":"Acupuncture and Herbal Medicine","volume":"5 2","pages":"160-172"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147921636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yue-Yue Tan, Mengyuan Wang, Yu-Nuo Fan, Ya‐Liu Fan, Ye Zhang, Bin Li, Yong‐Xiang Wang, Hua Yang, Ping Li
{"title":"Characterization of metabolic profiles of Lanqin Oral Liquid in rats by ultra-high-performance liquid chromatography tandem time-of-flight mass spectrometry","authors":"Yue-Yue Tan, Mengyuan Wang, Yu-Nuo Fan, Ya‐Liu Fan, Ye Zhang, Bin Li, Yong‐Xiang Wang, Hua Yang, Ping Li","doi":"10.1097/hm9.0000000000000149","DOIUrl":"https://doi.org/10.1097/hm9.0000000000000149","url":null,"abstract":"Objective: Lanqin oral liquid (LOL), as a traditional Chinese medicine prescription, has obvious clinical efficacy in the treatment of pharyngeal inflammation. Exploring the distribution of LOL prototype components and metabolites in plasma is of great significance for understanding potentially effective compounds. The aim of this study is to elucidate the metabolites and main metabolic pathways of LQL in vivo . Methods: In this study, a reliable approach integrated background subtraction and mass defect filtering (MDF), based on quadrupole time-of-flight mass spectrometry (QTOF-MS) technology, was performed to systematically scan the metabolites of LOL in rat plasma. In addition, according to the prototype mass spectrometry fragmentation pattern and combined with metabolic pathway analysis, a biotransformation oriented analysis strategy was established and applied to the identification of metabolites in LOL in vivo . Results: As a result, 159 compounds (58 prototypes and 101 metabolites) were identified or tentatively characterized in drug-containing plasma, including 74 flavonoids, 30 alkaloids, 34 terpenoids, five phenylpropanoids, six phenolic acids, five fatty acids, and five other type components. The main metabolic pathways include methylation, demethylation, hydroxylation, hydrogenation, glucuronidation, and sulfation. Conclusions: This study provides an overall characterization of the metabolites of LOL in vivo for the first time, providing a solid material basis for exploring the therapeutic effects and pharmacological mechanisms of LOL.","PeriodicalId":60507,"journal":{"name":"Acupuncture and Herbal Medicine","volume":"5 1","pages":"76-88"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147877651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Protective effect of Camellia nitidissima Chi on γ rays radiation-induced hematopoietic and gastrointestinal damage","authors":"Zhiyun Wang, Haihua Shang, Wenfeng Gou, Feifei Xu, Yue Hou, Gaiting Liu, Zhonghao Ren, Yiliang Li, Yuhua Tian, Wei Li, Yuefei Wang, Wenbin Hou","doi":"10.1097/hm9.0000000000000127","DOIUrl":"https://doi.org/10.1097/hm9.0000000000000127","url":null,"abstract":"Objective: Camellia nitidissima Chi, a Chinese medicine commonly used by ethnic minorities in Guangxi, China, is beneficial for clearing heat, detoxifying, inducing diuresis, and suppressing swelling. It has various pharmacological properties, including antitumor, anti-inflammatory, and antioxidant. However, its potential application in radioprotection remains unclear. In this study, we aimed to determine whether Camellia nitidissima Chi has radioprotective effects against radiation-induced gastrointestinal and hematopoietic damage. Methods: The 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical and 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) techniques were used to assess the ability of Camellia nitidissima Chi to scavenge free radicals. We conducted a 30-day survival rate experiment to evaluate the radioprotective capabilities of Camellia nitidissima Chi. Additionally, we developed models of radiation-induced intestinal and hematopoietic damage. Alterations in the white blood cell (WBC) count, total superoxide dismutase (T-SOD), glutathione (GSH), and protein expression linked to apoptosis were observed. Results: Camellia nitidissima Chi scavenged 84.72% and 93.47% of DPPH and ABTS, had a certain radiation protection potential, and increased the survival rate of mice to over 90%. Moreover, following exposure, Camellia nitidissima Chi enhanced WBC, T-SOD, and GSH levels. Camellia nitidissima Chi increased B-cell lymphoma-extra large (BCL-XL) expression and suppressed Bcl-2 associated X protein (BAX) expression, providing radioprotection to cells. Conclusions: Camellia nitidissima Chi has a strong antioxidant ability; it can improve the survival rate of mice after lethal dose irradiation and protect against radiation-induced hematopoietic and gastrointestinal damage. These findings can serve as a guide for using Chinese medicines for radioprotection.","PeriodicalId":60507,"journal":{"name":"Acupuncture and Herbal Medicine","volume":"4 4","pages":"487-499"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147899103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Junhui Ren, Na Li, Xi Danning, Naixuan Wei, Xiaomei Shao, Boyi Liu, Yi Liang, Junying Du, Xiaomin Jin, Jianqiao Fang, Junfan Fang
{"title":"Role of mast cell in hyperalgesic priming and the preventive effect of electroacupuncture on the transition from acute to chronic pain","authors":"Junhui Ren, Na Li, Xi Danning, Naixuan Wei, Xiaomei Shao, Boyi Liu, Yi Liang, Junying Du, Xiaomin Jin, Jianqiao Fang, Junfan Fang","doi":"10.1097/hm9.0000000000000140","DOIUrl":"https://doi.org/10.1097/hm9.0000000000000140","url":null,"abstract":"Objective: Injury can lead to long-term changes that increase the sensitivity of afferent nerve endings to subsequent stimulation and pain can transition from acute to chronic. This phenomenon is known as hyperalgesic priming (HP). This study aimed to understand the mechanisms underlying the effect of electroacupuncture (EA) on HP and optimize acupoint selection for EA to prevent pain transition. Methods: A rat HP model was established using sequential intraplantar injections of carrageenan (Cg) and prostaglandin E2 (PGE2). The pain thresholds were measured using von Frey filaments. EA on bilateral Zusanli (ST36) and Kunlun (BL60) was used to prevent pain transition. The number of mast cells in the ipsilateral hindpaw skin was determined using toluidine blue or fluorescence-labeled avidin staining. The protein expression levels of protein kinase C epsilon (PKCε) in the lumbar dorsal root ganglions (DRGs) were detected by western blotting 24 h after PGE2 injection. Serial pharmacological experiments were conducted to evaluate the relationship between mast cells and pain transition. Finally, EA on the bilateral ST36 and Chongyang (ST42) or a novel combination (ST36 and ST42 on the ipsilateral side, and ST36 and BL60 on the contralateral side) was used to prevent pain transition. Results: Although EA applied to ST36 and BL60 alleviated acute pain induced by Cg injection, it failed to prevent the pain transition caused by PGE2 injection. Mast cell accumulation in the ipsilateral hind paw was observed 7 days after Cg injection. Furthermore, mast cell degranulation may be responsible for PKCε activation in the DRG, a marker of pain transition. EA significantly decreased the number of mast cells in the skin of the ipsilateral hind paw when applied at ST36 and ST42, but not when applied at ST36 and BL60. Furthermore, EA employed to ST36 and ST42 significantly reversed long-term hyperalgesia induced by PGE2 injection, even when administered before injection. However, EA did not alleviate acute pain caused by Cg injection. By using a novel acupoint combination, EA simultaneously alleviated acute pain and prevented pain transition. Conclusions: Our study suggests that mast cells play a critical role in both HP and the transition from acute to chronic pain, whereas EA can prevent pain transition by decreasing the number of mast cells in the local tissue.","PeriodicalId":60507,"journal":{"name":"Acupuncture and Herbal Medicine","volume":"4 4","pages":"525-537"},"PeriodicalIF":0.0,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147911596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Danlei Wang, Haiyin Hu, Yucong Ma, Dehui Peng, Junhua Zhang, Alice Josephine Fauci, Zhaochen Ji
{"title":"Clinical Research Report on Traditional Chinese patent medicines and Traditional Chinese Classic Famous Prescriptions (2022)","authors":"Danlei Wang, Haiyin Hu, Yucong Ma, Dehui Peng, Junhua Zhang, Alice Josephine Fauci, Zhaochen Ji","doi":"10.1097/hm9.0000000000000122","DOIUrl":"https://doi.org/10.1097/hm9.0000000000000122","url":null,"abstract":"\u0000 \u0000 To comprehensively summarize and analyze the basic situation and methodological quality of clinical randomized controlled trials (RCTs) of Chinese and English traditional Chinese patent medicines and traditional Chinese classic famous prescriptions published in 2022, to provide evidence and reasonable suggestions for the advancement of clinical research and the formulation of policies and guidelines.\u0000 \u0000 \u0000 \u0000 The Evidence Database System of clinical evidence-based evaluation of traditional Chinese medicine was searched, and data from China National Knowledge Infrastructure (CNKI), PubMed, and other databases were supplemented. The search duration was from January 1, 2022, to December 31, 2022. RCTs of traditional Chinese patent medicines and traditional Chinese classic famous prescriptions were included as the source of clinical evidence, and published information, sample size, intervention, control measures, treatment course, methodological quality and key link report were analyzed and evaluated.\u0000 \u0000 \u0000 \u0000 A total of 1,464 RCTs of traditional Chinese patent medicines were included, which included 667 types of traditional Chinese patent medicines; \"traditional Chinese patent medicines+Western medicine vs. Western medicine\" was the most widely used intervention and control setting, involving 417 RCTs(28.48%). A total of 245 RCTs of traditional Chinese classic famous prescriptions were included, including 55 types of traditional Chinese classic famous prescriptions. \"Decoction+ conventional treatment vs. conventional treatment\" was the most widely used intervention and control setting, with 87 RCTs (35.51%). Published RCTs on traditional Chinese patent medicines and traditional Chinese classic famous prescriptions were limited by the study design and implementation. Most “allocation concealment” and “blinding of patients and personnel” were rated as medium to high risk,There are insufficient reports on key research links such as experimental registration and ethical approval.\u0000 \u0000 \u0000 \u0000 The number of RCTs on traditional Chinese patent medicines has decreased in 2022, but there has been a slight improvement in the research quality and impact. There are relatively few studies on traditional Chinese classic famous prescriptions. Measures must be taken to improve clinical trial design, implementation, and reporting. Methodological experts should be invited to provide professional technical guidance on the trial design. In the research implementation process, attention should be paid to quality control, particularly the standardization of the randomized execution.\u0000","PeriodicalId":60507,"journal":{"name":"Acupuncture and Herbal Medicine","volume":"19 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141350817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Network Pharmacology and Bioinformatics Analysis identify potential therapeutic effects of Berberine on Colon Cancer complicated with Radiation Enteritis","authors":"Ziqiao Yan, Hongyang Yu, Liangliang Zhang, Zebin Liao, Xiangwei Ge, Yu-guo Wang, Peiyu Tian, Zhexin Ni, Yongqi Dou, Yue Gao","doi":"10.1097/hm9.0000000000000121","DOIUrl":"https://doi.org/10.1097/hm9.0000000000000121","url":null,"abstract":"\u0000 \u0000 Patients with colon adenocarcinoma (COAD) who undergo radiation therapy develop radiation enteritis (RE). The predictive value of RE in COAD is yet to be established. Berberine, an active compound derived from the traditional Chinese medicinal plant, Coptis chinensis, has notable anti-inflammatory properties and offers protection to the intestinal mucosa. This study aimed to evaluate the possible therapeutic effect and mechanism of berberine as a treatment for COAD complicated with RE (COAD&RE).\u0000 \u0000 \u0000 \u0000 Relevant genetic features of diverse COAD&RE populations were analyzed using bioinformatics and the Cox proportional hazards regression model. The therapeutic targets of berberine were predicted using network pharmacology and molecular docking. In vivo and in vitro experiments were conducted to validate the core genes identified using molecular docking.\u0000 \u0000 \u0000 \u0000 RE has a certain impact on the prognosis of COAD and berberine may play an important role in the treatment of COAD&RE. In addition, we identified five core therapeutic targets of berberine by network pharmacology and molecular docking: CCND1, MYC, AR, LEP, and CYP19A1. In vivo experiments showed that berberine increased short-term survival rate, body weight, and intestinal epithelial cell recovery in mice after radiation. In an in vitro study, berberine promoted the proliferation of human intestinal epithelial cells and enhanced the radiosensitivity of HT29 cells after radiation, and the relative mRNA expression levels of CCND1 and MYC closely correlated with these effects.\u0000 \u0000 \u0000 \u0000 This study predicted the potential therapeutic effects of berberine on COAD&RE and verified the relevant mechanisms, which may provide insights and suggestions for the clinical treatment of COAD&RE.\u0000","PeriodicalId":60507,"journal":{"name":"Acupuncture and Herbal Medicine","volume":"9 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141354245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}